Sanofi SA (EPA: SAN) is in focus today after teaming up with OpenAI to deploy artificial intelligence for drug development.

, opens new tab on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects through the use of Artificial ...

French pharmaceutical company Sanofi is partnering with Sam Altman's OpenAI and AI pharma company Formation Bio to expedite the development of new medicines, tapping artificial intelligence to ...

French pharmaceutical company Sanofi announced Tuesday a partnership with ChatGPT-founder OpenAI and US biotech firm Formation Bio to accelerate the use of artificial intelligence in developing ...

Sanofi said in a statement that the partnership with OpenAi will allow it to access proprietary data to develop AI models for its biopharma models, while Formation Bio will provide additional ...

We all want a crystal ball, something that will let us peer a few months into the future and know how the markets are going to shake out. Of course, that won’t happen – but it won’t stop ...

(Reuters) - French drugmaker Sanofi (NASDAQ:SNY) on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects ...